Nevada § 442.630 Test used must be approved by United States Food and Drug Administration; requirements for administration of test

Nevada Statutes

§ 442.630 — Test used must be approved by United States Food and Drug Administration; requirements for administration of test

Nevada § 442.630

Title 40PUBLIC HEALTH AND SAFETY

Ch. 442Maternal

TESTING OF PREGNANT WOMEN AND NEWBORN CHILDREN FOR HUMAN IMMUNODEFICIENCY VIRUS

This text of Nevada § 442.630 (Test used must be approved by United States Food and Drug Administration; requirements for administration of test) is published on Counsel Stack Legal Research, covering Nevada primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Nev. Rev. Stat. § 442.630 (2026).

Text

1. Any test for the human immunodeficiency virus, including, without limitation, a rapid test, that is used to carry out the provisions of NRS 442.600 to 442.660 , inclusive, must be approved by the United States Food and Drug Administration. 2. Each test administered to a woman or performed on a child pursuant to the provisions of NRS 442.600 to 442.660 , inclusive, must be administered or performed in accordance with:

(a)The provisions of chapter 652 of NRS and any regulations adopted pursuant thereto; and

(b)The Clinical Laboratory Improvement Amendments of 1988, Public Law No. 100-578, 42 U.S.C. § 263a, if applicable.

Free access — add to your briefcase to read the full text and ask questions with AI

1. Any test for the human immunodeficiency virus, including, without limitation, a rapid test, that is used to carry out the provisions of NRS 442.600 to 442.660 , inclusive, must be approved by the United States Food and Drug Administration.
2. Each test administered to a woman or performed on a child pursuant to the provisions of NRS 442.600 to 442.660 , inclusive, must be administered or performed in accordance with:
(a) The provisions of chapter 652 of NRS and any regulations adopted pursuant thereto; and
(b) The Clinical Laboratory Improvement Amendments of 1988, Public Law No. 100-578, 42 U.S.C. § 263a, if applicable.